Qualitative longitudinal analysis of symptoms in patients with primary and metastatic brain tumours

被引:19
作者
Rijmen, Frank [2 ]
Ip, Edward H. [1 ]
Rapp, Stephen [1 ]
Shaw, Edward G. [1 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Biomed Sci, Winston Salem, NC 27157 USA
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
关键词
brain tumours; hidden Markov model; latent class; quality of life; transition probability;
D O I
10.1111/j.1467-985X.2008.00529.x
中图分类号
O1 [数学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 0701 ; 070101 ;
摘要
Primary and metastatic brain tumour patients are treated with surgery, radiation therapy and chemotherapy. Such treatments often result in short- and long-term symptoms that impact cognitive, emotional and physical function. Therefore, understanding the transition of symptom burden over time is important for guiding treatment and follow-up of brain tumour patients with symptom-specific interventions. We describe the use of a hidden Markov model with person-specific random effects for the temporal pattern of symptom burden. Clinically relevant covariates are also incorporated in the analysis through the use of generalized linear models.
引用
收藏
页码:739 / 753
页数:15
相关论文
共 45 条
[1]   A general maximum likelihood analysis of variance components in generalized linear models [J].
Aitkin, M .
BIOMETRICS, 1999, 55 (01) :117-128
[2]   Application of hidden Markov models to multiple sclerosis lesion count data [J].
Altman, RM ;
Petkau, AJ .
STATISTICS IN MEDICINE, 2005, 24 (15) :2335-2344
[3]  
[Anonymous], 2001, COMPUTING SCI STAT
[4]  
[Anonymous], 2002, ANAL LONGITUDINAL DA
[5]   Latent variable regression for multiple discrete outcomes [J].
Bandeen-Roche, K ;
Miglioretti, DL ;
Zeger, SL ;
Rathouz, PJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1997, 92 (440) :1375-1386
[6]   STATISTICAL INFERENCE FOR PROBABILISTIC FUNCTIONS OF FINITE STATE MARKOV CHAINS [J].
BAUM, LE ;
PETRIE, T .
ANNALS OF MATHEMATICAL STATISTICS, 1966, 37 (06) :1554-&
[7]   Applications of continuous time hidden Markov models to the study of misclassified disease outcomes [J].
Bureau, A ;
Shiboski, S ;
Hughes, JP .
STATISTICS IN MEDICINE, 2003, 22 (03) :441-462
[8]   A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCL in brain tumor patients receiving radiation therapy [J].
Butler, Jerome M., Jr. ;
Case, L. Douglas ;
Atkins, James ;
Frizzell, Bart ;
Sanders, George ;
Griffin, Patricia ;
Lesser, Glenn ;
Mcmullen, Kevin ;
Mcquellon, Richard ;
Naughton, Michelle ;
Rapp, Stephen ;
Stieber, Volker ;
Shaw, Edward G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05) :1496-1501
[9]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[10]   Longitudinal profiling of health care units based on continuous and discrete patient outcomes [J].
Daniels, MJ ;
Normand, SLT .
BIOSTATISTICS, 2006, 7 (01) :1-15